ArticleCureus2025
Telangiectasia Macularis Eruptiva Perstans Following Radiotherapy: Atypical Presentation of a Rare Condition.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Telangiectasia macularis eruptiva perstans (TMEP) is a rare form of cutaneous mastocytosis characterized by telangiectatic macules and plaques. We report an atypical case of TMEP in an 80-year-old female with a history of left invasive lobular carcinoma, previously treated with mastectomy, radiotherapy, and hormonal therapy. The patient presented with a single telangiectatic plaque on the left side of her trunk. Histopathological examination confirmed the diagnosis of TMEP. This case is notable due to the patient's advanced age and the history of extensive cancer treatment, including radiation therapy. The potential association between radiation therapy and the development of mast cell disorders is explored, considering the possible role of radiation-induced skin changes in the pathogenesis of TMEP. This case underscores the importance of considering TMEP in the differential diagnosis of telangiectatic lesions, particularly in patients with a history of malignancy and radiation therapy. Further research is warranted to elucidate the mechanisms linking radiation therapy to mast cell proliferation and activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.